Dear Editor,Intraoperative radiotherapy(IORT)is an accelerated par-tial breast irradiation(APBI)treatment that is accom-plished intraoperatively.Numerous clinical trials indicate that IORT is safe and effective,non-in...Dear Editor,Intraoperative radiotherapy(IORT)is an accelerated par-tial breast irradiation(APBI)treatment that is accom-plished intraoperatively.Numerous clinical trials indicate that IORT is safe and effective,non-inferior to standard whole-breast external beam radiotherapy(EBRT)for low-risk patients who receive breast-conserving surgery[1-3].Nevertheless,these studies mainly included non-Asians and thus lack adequate evidence to support the value of IORT in Asian patients with breast cancer.展开更多
基金supported by the National Key Research and Development Program of China(Grant No.2019YFE0110000),Beijing Municipal Science&Technol-ogy Commission(D161100000816003),National Natural Science Foundation of China(Grant No.82072097),Clin-ical and Translational Medicine Research Foundation of Chinese Academy of Medical Sciences(Grant No.2020-I2M-C&T-B-069),the CAMS Initiative Fund for Medical Sciences(Grant No.2017-I2M-3-004),the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences(Grant No.2018PT32013,2017PT32001 and 2016ZX310178),Beijing Hope Run Special Fund of Cancer Foundation of China(Grant No.LC2017B15 and LC2020A18).
文摘Dear Editor,Intraoperative radiotherapy(IORT)is an accelerated par-tial breast irradiation(APBI)treatment that is accom-plished intraoperatively.Numerous clinical trials indicate that IORT is safe and effective,non-inferior to standard whole-breast external beam radiotherapy(EBRT)for low-risk patients who receive breast-conserving surgery[1-3].Nevertheless,these studies mainly included non-Asians and thus lack adequate evidence to support the value of IORT in Asian patients with breast cancer.
